Dimensional Fund Advisors LP Buys 20,270 Shares of Exponent, Inc. $EXPO

Key Points

• Dimensional Fund Advisors increased its Exponent stake by 2.3%, purchasing 20,270 shares to own 918,885 shares valued at approximately $60.0 million. Institutional investors collectively own 92.37% of the company.
• Exponent exceeded quarterly expectations with earnings of $0.60 per share and revenue of $171.6 million, up 12% year over year. Management also raised its 2026 revenue-growth outlook to 9%–10%, citing demand related to artificial intelligence.
• The company declared a quarterly dividend of $0.31 per share, representing a 1.9% annualized yield, while JPMorgan raised its price target to $90 and maintained an “overweight” rating. However, insiders have reported sales and no purchases in recent months.

Dimensional Fund Advisors LP increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 918,885 shares of the business services provider's stock after purchasing an additional 20,270 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.89% of Exponent worth $59,958,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in EXPO. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Exponent by 87,479.8% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 230,335 shares of the business services provider's stock worth $15,999,000 after buying an additional 230,072 shares in the last quarter. UBS Group AG lifted its stake in shares of Exponent by 29.7% in the 4th quarter. UBS Group AG now owns 176,404 shares of the business services provider's stock valued at $12,253,000 after acquiring an additional 40,359 shares during the last quarter. Vest Financial LLC boosted its holdings in shares of Exponent by 69.4% during the 4th quarter. Vest Financial LLC now owns 62,350 shares of the business services provider's stock valued at $4,331,000 after acquiring an additional 25,537 shares in the last quarter. Conestoga Capital Advisors LLC boosted its holdings in shares of Exponent by 1.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider's stock valued at $166,183,000 after acquiring an additional 31,303 shares in the last quarter. Finally, SG Americas Securities LLC grew its position in Exponent by 422.3% during the 4th quarter. SG Americas Securities LLC now owns 36,610 shares of the business services provider's stock worth $2,543,000 after acquiring an additional 29,600 shares during the last quarter. Institutional investors own 92.37% of the company's stock.

Exponent Stock Performance

EXPO stock opened at $66.85 on Friday. The company has a fifty day moving average price of $60.00 and a 200-day moving average price of $65.23. The company has a market capitalization of $3.24 billion, a P/E ratio of 29.98 and a beta of 0.72. Exponent, Inc. has a 52-week low of $51.91 and a 52-week high of $81.95.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 29.63%. The company had revenue of $171.61 million for the quarter, compared to analyst estimates of $144.99 million. During the same quarter in the previous year, the business earned $0.52 earnings per share. Exponent's revenue was up 12.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Exponent, Inc. will post 2.3 earnings per share for the current fiscal year.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be issued a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 annualized dividend and a yield of 1.9%. Exponent's payout ratio is presently 55.61%.

Insider Buying and Selling

In other Exponent news, CEO Catherine Corrigan sold 4,194 shares of the company's stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $54.06, for a total value of $226,727.64. Following the sale, the chief executive officer owned 105,218 shares in the company, valued at approximately $5,688,085.08. The trade was a 3.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Joseph Sala sold 2,066 shares of the stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $56.66, for a total value of $117,059.56. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,324 shares of company stock valued at $855,019 over the last 90 days. 1.60% of the stock is owned by corporate insiders.

Exponent News Summary

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations: Exponent reported adjusted earnings of $0.60 per share versus the $0.55 consensus estimate. Revenue reached approximately $171.6 million, while operating profit rose 63.1% year over year to $28.0 million. Exponent Q2 earnings report
• Positive Sentiment: Growth outlook raised: Management increased its 2026 net revenue growth forecast to 9%–10%, citing expanding demand for services related to artificial intelligence. The improved guidance reinforces expectations for continued business momentum. Exponent raises 2026 growth outlook
• Positive Sentiment: JPMorgan raised its price target: JPMorgan Chase increased its target from $80 to $90 and assigned an “overweight” rating, implying substantial potential appreciation from the referenced $66.94 price. JPMorgan raises Exponent price target
• Positive Sentiment: Capital returns increased: The board declared a quarterly dividend of $0.31 per share and expanded the company’s stock-repurchase authorization by $50 million. Exponent dividend and repurchase announcement
• Neutral Sentiment: The dividend offers an annualized yield of roughly 1.9%, with payment scheduled for September 18 to shareholders of record on September 4.
• Negative Sentiment: Insider-trading data showed 17 reported insider sales and no purchases over the past six months, which may raise a modest sentiment concern. Quarterly operating cash flow was also negative at $1.0 million, although capital spending remained limited at $2.5 million.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. JPMorgan Chase & Co. upped their target price on Exponent from $80.00 to $90.00 and gave the stock an "overweight" rating in a report on Friday. Weiss Ratings reissued a "hold (c-)" rating on shares of Exponent in a research note on Friday, July 17th. Finally, UBS Group set a $72.00 price target on Exponent and gave the stock a "neutral" rating in a report on Friday. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $81.00.

Exponent Company Profile

Exponent, Inc NASDAQ: EXPO is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.